Press releases | WebDisclosure

Basculer en Français

9587	Companies
190037	Keywords
121565	Articles
101301	Press releases

Home
Press releases

REGULATED PRESS RELEASE

published on 09/01/2025 at 07:00, 4 months 1 day ago

Biophytis dévoile sa stratégie pour l’essai clinique de phase 2 dans l’obésité avec BIO101 en Europe et au Brésil
Biophytis dévoile sa stratégie pour l’essai clinique de phase 2 dans l’obésité avec BIO101 en Europe et au Brésil. Mise à jour détaillée du plan clinique et réglementaire visant à étendre le potentiel de BIO101

Biophytis Europe Essai Clinique BIO101 Obésité
REGULATED PRESS RELEASE

published on 09/01/2025 at 07:00, 4 months 1 day ago

Biophytis unveils Phase 2 Obesity Trial Strategy with BIO101 in Europe and Brazil
Biophytis reveals Phase 2 Obesity Trial Strategy for BIO101 in Europe and Brazil, targeting muscle wasting in obese patients. Expanding therapeutic horizons and commercial prospects

Biophytis Phase 2 BIO101 Muscle Wasting Obesity Trial
PRESS RELEASE

published on 09/01/2025 at 07:00, 4 months 1 day ago

Les actionnaires de WNS approuvent l’acquisition par Capgemini
Les actionnaires de WNS approuvent l'acquisition par Capgemini. L'opération de 3,3 milliards de dollars vise à créer un leader mondial des Opérations Intelligentes

Acquisition IA Capgemini WNS Opérations Intelligentes
PRESS RELEASE

published on 09/01/2025 at 07:00, 4 months 1 day ago

Acquisition of WNS approved by its shareholders
Capgemini announces approval of WNS acquisition by its shareholders, creating a global leader in Agentic AI-powered Intelligent Operations. Closing expected by year-end amidst regulatory approvals

Regulatory Approvals Shareholders Approval Capgemini WNS Acquisition AI-powered Operations
PRESS RELEASE

published on 09/01/2025 at 06:59, 4 months 1 day ago

Biophytis dévoile sa stratégie pour l’essai clinique de phase 2 dans l’obésité avec BIO101 en Europe et au Brésil
Biophytis dévoile sa stratégie pour l’essai clinique de phase 2 dans l’obésité avec BIO101 en Europe et au Brésil. Mise à jour détaillée du plan clinique et réglementaire, ambitions et enjeux commerciaux

Biophytis Europe Essai Clinique BIO101 Obésité
PRESS RELEASE

published on 09/01/2025 at 06:59, 4 months 1 day ago

Biophytis unveils Phase 2 Obesity Trial Strategy with BIO101 in Europe and Brazil
Biophytis unveils Phase 2 Obesity Trial Strategy for BIO101 in Europe and Brazil, targeting muscle wasting associated with obesity. The new program broadens potential and value-creation opportunities globally

Biophytis Phase 2 BIO101 Muscle Wasting Obesity Trial
PRESS RELEASE

published on 08/31/2025 at 18:00, 4 months 2 days ago

Déclaration des transactions sur actions propres
KLEA HOLDING annonce des rachats d'actions propres conformes au règlement MAR et présente son activité centrée sur l'acquisition, le développement et la digitalisation d'entreprises

Acquisition Développement Digitalisation Rachats D'actions Klea Holding
PRESS RELEASE

published on 08/31/2025 at 12:17, 4 months 2 days ago

EQS-Adhoc: Gateway Real Estate AG: Value adjustments weigh on preliminary figures for fiscal year 2024
Gateway Real Estate AG announces value adjustments affecting preliminary figures for fiscal year 2024 due to real estate reassessment, impacting EBIT and EBT

EBIT Fiscal Year 2024 EBT Gateway Real Estate AG Value Adjustments
PRESS RELEASE

published on 08/30/2025 at 14:00, 4 months 3 days ago

Sparta Releases Q3 2025 Financial Results
Sparta Group (TSXV:SAY) releases financial results for Q3 2025 & 2024, highlights advancements in recycling, medical tech pilot, large Bay contract, innovation & carbon credit program

Financial Results Medical Technology Sparta Group Recycling Carbon Credit Program
PRESS RELEASE

published on 08/30/2025 at 02:10, 4 months 3 days ago

GLG Life Tech Corporation Reports 2025 Second Quarter Financial Results
GLG Life Tech Corporation announces financial results for the three and six months ended June 30, 2025, including revenue decrease of 22% and net income increase. Company emphasizes managing SG&A expenses

Financial Results Revenue Decrease GLG Life Tech Corporation Net Income Increase SG&A Expenses

Accesswire

Published on 01/02/2026 at 23:00, 17 minutes ago

Pinetree Capital Announces Chief Investment Officer's Return from Leave of Absence
Published on 01/02/2026 at 22:45, 32 minutes ago

ATHA Energy Announces Grant of Compensation Securities
Published on 01/02/2026 at 19:50, 3 hours 27 minutes ago

Datavault AI and The Dream Bowl to Set New Benchmark in Sports Innovation with World’s First Tokenized Autograph Session, Featuring Current and Future NFL Stars - Live on ESPN+
Published on 01/02/2026 at 15:00, 8 hours 17 minutes ago

Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Published on 01/02/2026 at 14:00, 9 hours 17 minutes ago

Metallic Minerals Provides Corporate Update and Responds to Recent Market Activity

View all ACCESSWIRE

EQS Group

Published on 01/02/2026 at 21:29, 1 hour 47 minutes ago

Crédit Mutuel Alliance Fédérale completes the acquisition of OLB and scales up in Germany
Published on 01/02/2026 at 18:55, 4 hours 22 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 01/02/2026 at 18:43, 4 hours 34 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/02/2026 at 18:25, 4 hours 52 minutes ago

Bitmine Publishes New Chairman's Message Explaining Why Shareholders Should Vote YES to Approve the Amendment to Increase Authorized Shares
Published on 01/02/2026 at 17:59, 5 hours 18 minutes ago

POS-Transaction in Own Shares

Les Echos

Published on 01/02/2026 at 17:45, 5 hours 32 minutes ago

Mise en ligne du document « Pre-FY 2025 Results Communication »
Published on 01/02/2026 at 17:45, 5 hours 32 minutes ago

Availability of the Pre-FY 2025 Results Communication
Published on 12/29/2025 at 19:14, 4 days 4 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 22 au 26 décembre 2025 dans le cadre du programme de rachat d’actions.
Published on 12/29/2025 at 18:05, 4 days 5 hours ago

Covivio - Déclaration des transactions sur actions propres réalisées du 22 décembre au 24 décembre 2025
Published on 12/29/2025 at 18:05, 4 days 5 hours ago

Covivio - Treasury shares transactions between December 22nd , 2025 and December 24th, 2025

View all LES ECHOS COMFI WIRE